
    
      To compare aqueous levels of inflammatory cytokines in diabetic and non diabetic patients
      treated with preoperative topical ketorolac tromethamine 0.45%.

      To compare the macular thickness changes in diabetic and non diabetic patients treated with
      preoperative ketorolac tromethamine 0.45% and its correlation with the aqueous inflammatory
      cytokines.
    
  